Clinical trial
Sugammadex Compared With Neostigmine/Glycopyrrolate in Impact of Postoperative Urinary Retention for ENT Surgery Patients With High-risk of Dysuria
NCT06398899 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sugammadex Compared With Neostigmine/Glycopyrrolate in Impact of Postoperative Urinary Retention for ENT Surgery Patients With High-risk of Dysuria
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 1, 2024
- Completion date
- August 12, 2025
- Enrollment
- 124 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic otitis media, chronic sinusitis, head and neck surgery, laryngeal disease